Lidocaine Hydrochloride 8 mg / mL Injection 250 mL (Lidocaine Hydrochloride and Dextrose)
Comprehensive product details for sourcing and verification.
| NDC 11 | 00338-0411-02 |
|---|---|
| Product NDC | 00338-0411 |
| Generic Drug Name | Lidocaine Hydrochloride |
| Brand Name | Lidocaine Hydrochloride and Dextrose |
| Manufacturer | Baxter Healthcare Corporation |
| Strength | 8 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 24 Bag |
| Package Description | 24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAG |
| Active Ingredients | Lidocaine Hydrochloride |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Lidocaine Hydrochloride 8 mg / mL Injection is tracked under NDC 00338-0411-02 and rolls up into product family 00338-0411. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 24 Bag.
- Manufacturer: Baxter Healthcare Corporation.
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
This NDC appeared in documented shortage listings more than once between 2011 and 2018, a repeat pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Lidocaine Hydrochloride in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Lidocaine Hydrochloride.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Lidocaine Hydrochloride 8 mg / mL Injection 250 mL (Lidocaine Hydrochloride and Dextrose), NDC 00338-0411-02, is a Baxter Healthcare Corporation 8 mg / mL injection presentation packaged as 24 Bag. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00338-0411-02.
- Digits-only NDC 11: 00338041102.
- Possible 10-digit display formats: 0338-0411-02 (0338041102), 00338-411-02 (0033841102), 00338-0411-2 (0033804112).
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Lidocaine Hydrochloride and Dextrose.
- Exact NDC 11: 00338-0411-02.
- Product family NDC: 00338-0411.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.